@WelshBuffett
The only deal that I remember was from Gilead to Gritsone back in 2021.
under the terms Gilead paid Gritstone
- $30M in cash +30M in equity
- paid cost for HIV phase 1 clinical trial
- esclusive license to develop and commercialize it beyond phase 1
- 725M in regulatory and commercial milestone + royalties
- I am not sure if I missed anything else.
This was for phase 1. Imagine the possibilities for phase 3 HIV clinical trial for BIT.
We obviously don't know what's happening with Biotron and one day, hopefully soon, it will all be revealed.
@WelshBuffett The only deal that I remember was from Gilead to...
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.011(39.3%) |
Mkt cap ! $15.33M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.5¢ | 1.7¢ | $374.7K | 18.97M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1266038 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 689330 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |